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Summary
Activation of LysR type transcription factors (LTTRs) is thought to result from conformational changes that occur when inducer molecules bind to their Inducer Binding Domains (IBDs). However, the exact nature of these changes remains to be fully elucidated. We present the crystal structures of two truncated constructs of the LTTR DntR in their apo-forms and in complex with its natural induce. These provide a clearer picture of conformational changes that occur in LTTR IBDs and offer insights into the mechanism of activation of LTTRs. Two of the crystal structures shows that DntR IBDs can bind up to two inducer molecules. The full extent of conformational changes is achieved only when inducer molecules are bound in both binding sites identified. Point mutations disrupting the putative secondary binding site produce DntR variants with a reduced response to salicylate in a whole cell system, suggesting that this site is functionally relevant.
Introduction
4
LTTRs are available (CbnR, Muraoka et al., 2003a,b; TsaR, Monferrer et al., 2010; ArgP, Zhou et al., 2010; CrgA, Sainsbury et al., 2009; PA01 and PA0477 from Pseudomonas aeruginosa, unpublished, PDB codes 3FZV and 2ESN respectively; BenM, Ruangprasert et al., 2010) none of these are in complex with DNA or co-crystallised with a natural inducer. Nevertheless, these studies show that LTTR monomers can adopt two major conformations: 'compact' and 'extended'. In compact monomers the helix linking the IBD and DBD folds back over the surface of the IBD. In the extended conformation, the linker helix protrudes, to a greater or lesser degree, away from the IBD. Full length LTTRs form dimers as a result of the association of the linker helices and DBDs of two LTTR monomers.
When full-length LTTRs associate as homotetramers (CbnR, TsaR, ArgP, PA01, PA0477, BenM) two of the dimers described above associate to form a V-shaped entity comprising a tetrameric IBD core flanked at either end by a dimeric wHTH DNA binding region.. The tetrameric core is made up of two IBD dimers where, in each dimer, the two monomers are arranged in a headto-tail fashion. Interestingly, variations are found within the core regions of different full length LTTRs homotetramers. In the crystal structures of CbnR (Muraoka et al., 2003) , BenM (Ruangprasert et al., 2010) and inducer-free DntR (Smirnova et al., 2004 ) the tetrameric core adopts a compressed conformation in which the RD2s of the IBDs at the tetramer interface interact. In contrast, in TsaR (Monferrer et al., 2010) and ArgP (Zhou et al., 2010 ) the IBDs at the tetramer interface do not interact and these assume a more open expanded conformation (Supplemental Figure   1 ).
The functional roles (if any) of the compressed and expanded tetramer conformations observed is unclear. It was suggested, based on an analysis of the crystal structures of the IBDs of BenM and CatM (Ezezika et al., 2007) that activated LTTR homotetramers adopt a compressed tetramer configuration. However, in contrast, Monferrer and colleagues (Monferrer et al., 2010) proposed that compressed tetramers represent the inactive form of LTTRs and that, upon inducer 5 binding and thus activation, LTTRs adopt an expanded conformation. However, crystal structures of inducer-bound and inducer-free crystal structures of TsaR on which this latter hypothesis was partly based reveal no significant conformational differences and the idea that inducer-binding provokes a change from a compressed to an expanded conformation in LTTR tetramers which, in turn, leads to transcriptional activation is thus not yet proven. Indeed, that the crystal structures of inducer-free fulllength BenM and those of two full-length BenM mutants that activate transcription in the absence of inducer molecules are essentially identical (Ruangprasert et al., 2010) , suggests that conformational changes may play only a minor role in LTTR activation.
The LTTR DntR regulates the first steps in the oxidative degradation of 2,4-dinitrotoluene (2,4-DNT) by Burkholderia sp. strain DNT (Spanggord et al., 1991; Suen & Spain 1992) and Burkholderia cepacia R34 (Nishino et al., 2000; Johnson et al. 2002) . For this reason, DntR from Burkholderia sp. strain DNT coupled to the reporter gene, gfp (encoding Green Fluorescent Protein, GFP), was used to develop a prototype biosensor for 2,4-DNT (Ng & Forsman 2000) . This prototype biosensor had only a very limited response to 2,4-DNT but was very responsive to salicylic acid, an intermediate compound in the degradation of naphthalene in several species of soil bacteria that express LTTRs closely related to DntR (Schell, 1985; Jones et al., 2003; Lessner et al., 2003) . Subsequent studies (Smirnova et al., 2004) showed that DntR binds salicylate with a dissociation constant (K d ) of ~ 4 µM. No K d for the binding of 2,4-DNT could be estimated at inducer concentrations of up to 120 µM. Thus, if the prototype biosensor is to be useful in the detection of 2,4-DNT either a different LTTR, with specific recognition of 2,4-DNT, should be used or the inducer binding specificity of DntR must be modified. We have chosen the latter approach (Smirnova et al., 2004; Lönneborg et al., 2006) which would be facilitated by knowledge of the threedimensional structure of DntR in complex with its natural inducer.
Our efforts to modify the inducer binding specificity of DntR were hampered by an inability to obtain crystals of full-length DntR in complex with salicylate. Recently, however, we have 6 produced two truncated versions of DntR (∆N90-DntR, residues 90 -301 of DntR; ∆N80-DntR, residues 80 -301) and have obtained crystal structures of both constructs in the apo-form and in complex with salicylate. The complexes represent the first crystals of an IBD of an LTTR obtained by co-crystallisation with a natural inducer/ligand.
The results of our crystal structure analyses allow an experimental determination of the mode of interaction between salicylate and DntR. They also provide, for the first time, a full picture of the conformational changes that can occur in the IBDs of LTTRs upon inducer binding. The ∆N90-DntRsalicylate crystal structures also suggest that the IBDs of DntR can bind up to two salicylate moieties, one in the primary DntR IBC, the second near the N-terminus of the IBD and that the full extent of conformational changes in the IBD is achieved only when salicylate molecules are bound at both sites. We examine the functional and structural relevance of the secondary inducer binding site and, based on the conformational changes we observe upon inducer molecule binding, present evidence that upon activation LTTR tetramers adopt an expanded, and not compressed, conformation.
Results
Inducer binding to
∆N90-DntR comprises residues 90-301 of full length DntR, contains a F90M mutation and consists of residues making up the IBD of DntR. ∆N80-DntR comprises the IBD plus 10 residues of the linker region and contains a L80M mutation. As expected, the IBD folds into the two subdomains, RD1 (residues 90-166 and 274-301) and RD2 (residues 171-269), linked by a hinge region (residues 167-170 and 270-273) ( Figure 1A ). In all the crystal structures described here IBD monomers associate as head-to-tail homodimers very similar in quaternary structure to that previously reported for the IBDs of LTTRs (Tyrell et al., 1997; Choi et al., 2001; Ezezika et al., 2007; Sainsbury et al., 2010; Quade et al., 2011 ) ( Figure 1B ). As expected (Smirnova et al., 2004) , the IBC of DntR is a cavity located at the RD1/RD2 interface ( Figure 2A , 2B). The aromatic ring of salicylate is enclosed in a pocket formed primarily by the side chains of aromatic and hydrophobic residues (I106, G107, Y110, F111, G152, F167, R248, I273). Hydrophilic interactions near the mouth of the pocket provide binding specificity: hydrogen bonds are formed between the hydroxyl group of the inducer and Nε2 of H169 and the O1' atom of the salicylate carboxyl group and Nε2 of H206, while water-mediated interactions between the inducer molecule and the main chain atoms of T104, L153 (both amide hydrogen) and L151
(carbonyl oxygen) further stabilise protein-ligand interactions. All of the residues listed above were predicted to be involved in salicylate binding by DntR in previous modelling studies (Smirnova et al., 2004) which were used as a basis for the design point mutations that broaden the inducer specificity of DntR (Lönneborg et al., 2007) . However, these modeling studies did not predict the exact nature of salicylate-DntR interactions. The interactions elucidated in the crystal structures described here will thus provide an unambiguous template for the modification of DntR in order to improve its response to 2,4-DNT.
Unexpectedly, our studies reveal a second salicylate binding site in the ∆N90-DntR-salicylate crystal structures ( Figure 3A ). This site is present in crystal form I and in the two monomers making up the A/B dimer in crystal form II. This second site is found in a cleft (the F90 cleft), close to the Nterminus of the ∆N90-DntR construct, formed by the displacement of the side chain of residue M90
(F90 in full-length DntR) from the hydrophobic pocket in which it is normally found. The cleft is formed by the side chains of M90 (crystal form I only), P92, S95, R97, F99, I126, P285, G286 and W289 ( Figure 3B ). As the cleft normally accommodates the side chain of a phenylalanine residue, it is ideally shaped to allow the binding of other single-ring aromatic moieties such as salicylate ( Figure   2B ). The pocket is not as specific for salicylate as is the DntR IBC and we observe different modes of salicylate binding in this region in crystal forms I and II, respectively ( Figures 3C, 3D ). Nevertheless, hydrophilic interactions (notably direct hydrogen bonds between the ligand oxygen atoms and S95 8 and a solvent-mediated interaction with the side chain of D284) provide some degree of specificity.
This secondary site was seen for none of the molecules in the a.u. of the crystal structure of ∆N80-DntR-salicylate.
Conformational changes upon inducer binding.
Superimposing the crystal structures of apo-and inducer bound ∆N80-and ∆N90-DntR onto the crystal structure of the IBD of full-length DntR in the absence of its natural inducer molecule (PDB code, 1UTB; Smirnova et al., 2004 ) using RD1 as a reference, reveals two major IBD conformations: open and closed (grey or blue in Figure 4A , Table 1 ). The closed conformation is seen only for ∆N90-DntR and occurs only when inducer molecules are bound in both the primary and secondary sites described above.
The transition from open to closed IBD conformations involves the rotation of RD2 towards RD1 during which the β8-α8 and β9-α9 loops (RD2) move closer to the β4-α6 loop of RD1 (see secondary structure labelling in Figure 1A ). When salicylate is bound in the IBC of an open DntR IBD conformer water molecules link the inducer molecule to the surface of the IBD. In the closed conformation the water molecules are expelled from the RD1-RD2 interface, a hydrogen bond is formed between the carbonyl oxygen of L153 (RD1) and the amide hydrogen of G205 (RD2) and the salicylate moiety becomes completely enfolded within the IBD ( Figure 4B ). Analysis of the domain motions using the DynDom Protein Domain Motion Analysis server (Hayward & Berendsen, 1998;  Figure 5A , Table 2 ) are consistent with the binding of only one inducer molecule, presumably in the IBC, with a K d ~10 µM depending on the construct (Table 2) . Similar results were obtained for ∆N90-DntR construct by monitoring intrinsic fluorescence quenching upon inducer binding (Supplemental Figure 5B ). The implications of this will be discussed below.
Experiments using whole-cell systems
In order to clarify if the apparent secondary site has a functional role, experiments using a whole-cell system containing a pQEwtdntRHis6:P DNT :gfp plasmid (see Lönneborg et al., 2007 for details) were performed. In this system, inducer binding to DntR, and subsequent transcriptional activation, leads to the expression of GFP. The resulting fluorescence is monitored by flow cytometry.
Experiments were performed using wt-DntR and three mutants (S95A, R97C, F90A) holding mutations in the proposed secondary inducer-binding site. Two mutations (R97C, F90A) drastically reduced the response to salicylate. The effect of the S95A mutation, while still significant, was less prominent ( Figure 5A ). Experiments were also performed using different compounds (2,4-DNT, 2-nitrotoluene, 4-nitrotoluene, 2-hydroxytoluene, 2-nitrobenzoic acid, 4-nitrobenzoic acid, benzoic acid) either separately or in combination with salicylate. As expected (Lönneborg et al., 2007) strain 4NT (Haigler & Spain, 1993) . Nitrobenzoates, including 4-NB, are also chemoattractants for Pseudomonas strains (Parales, 2004) .
Discussion
ITC and intrinsic fluorescence quenching do not provide evidence of a second salicylate binding site for the ∆N90-DntR construct, despite crystallographic evidence that there is one. This implies a relatively low K d for this site and could be an indication of the non-specific binding of salicylate to the ∆N90-DntR construct due both to the nature of the construct and the high concentration of the ligand in the crystallisation mixtures (see Experimental Procedures). However, a relatively low binding affinity for a secondary site is also observed for inducer binding to the IBD of BenM. Here, the K d for the co-inducer benzoate, which does not bind in the BenM IBC, is 1.1 mM (Ezezika et al., 2007; Clark et al., 2004) . Nevertheless, that we do not see evidence for a secondary inducer binding site in the crystal structure of the ∆80-DntR-salicylate complex suggests that caution should be exercised before definitively assigning this secondary site a functional role. There are, though, many reasons to believe that the secondary site identified may be relevant to the functionality of full-length DntR.
DntR is et al., 2003) where the homologous residue is V90. Thus, in DntR, F90 may form part of, and help to stabilise, the linker helix in activated extended conformers. In doing so, its side chain will vacate the cleft in which it is found in inactive DntR monomers leaving it available for the binding of other molecules with a suitable structure (i.e.
salicylate, Figure 6B ).
Crystal structures show that the direction of the linker helices relative to LTTR IBDs varies in both extended (Monferrer et al., 2010) and compact (Ruangprasert et al., 2010) monomers. This suggests that in solution the linker helices (and thus the positions of the DBDs) are mobile. In DntR this could mean that the F90 cleft could become available for ligand binding even in compact monomers ( Figure 6B ). In DntR, occupation of vacant F90 cleft by an inducer molecule may therefore help to define preferred orientations of the linker helices in both compact and extended monomers and thus to stabilise the active conformation of DntR.
Experiments using the whole-cell system show that mutations targeting two of the residues that line the putative second inducer binding site result in a lower response of DntR to salicylate ( Figure 5A ). The very reduced response of a R97C mutant can be explained by the fact that in wtDntR this residue forms a salt-bridge with D284. Disruption of this interaction could have serious consequences on the ability of DntR to adopt its active conformation. In the case of the more moderately reduced response of the S95A mutant, one possible explanation is that salicylate binding in the secondary site is important for DntR functionality and that, as for BenM, both primary and secondary inducer binding sites should be fully occupied for DntR to become fully active and that the S95A mutation, in line with the interactions seen the ∆N90-DntR-salicylate crystal structures, makes the putative second binding less receptive to salicylate.
Given the apparent low specificity of the putative secondary binding site for salicylate, experiments monitoring the in vivo response of pQEwtdntRHis6:PDNT:gfp-containing whole cells response to different molecules in combination with salicylate were designed to investigate whether molecules other than salicylate might bind in this site. The synergistic transcriptional response observed to a combination of salicylate and 4-NB ( Figure 5B ) suggests that such binding could be a possibility. However, the degree of synergism observed (~1.5 for wt-DntR, ~1.7 for S95A-DntR, ~1.3 for R97C-DntR) varies little between wt-DntR and mutants changing the characteristics of the F90 cleft. This suggests that 4-NB might not bind in the secondary site but rather in a third, as yet unidentified location in DntR. This intriguing possibility clearly requires further investigation.
Transcription activation by DntR
The crystal structures of inducer-free and inducer-bound BenM IBDs led Ezezika and represented the inactive form of LTTRs while the expanded configuration is the active form. Given that both these hypotheses were made on the basis of crystal structures showing either small (BenM) or no (TsaR) conformational changes upon inducer binding, of TsaR, it is still unclear which of these two proposals is more likely to be correct.
The crystal structures we describe here show that ligand induced conformational changes to 14 LTTR IBDs can be much larger than previously observed. Interestingly, when the crystal structures of open and fully closed DntR IBDs were superimposed (using RD1 as a reference) on the IBDs observed in crystal structures of TsaR (Monferrer et al., 2010) it is clear that the latter adopt a fully closed conformation ( Figure 4C ). We have previously determined the crystal structure of full-length
DntR in an open IBD conformation (Smirnova et al., 2004) . Here, the homotetramers observed adopt a compressed configuration. We tried to model the active form of DntR by aligning the fully-closed conformation of ∆N90-DntR with the IBDs in this crystal structure using the RD1s at the tetramer interface as a reference. This model results in a steric clash between contact helices from the RD2 subdomains at the tetramer interface ( Figure 6C ). This suggests that the closed IBD conformation The amplicon was ligated into the cloning ATG vector pQE60 (QIAGEN) and transformed by electroporation to E. coli M15[pREP4] cells. Protein expression and purification was carried out using two slightly different protocols: Protocol A: Bacteria were grown and ∆N90-DntR-His 6 purified as previously described for full length DntR (Smirnova et al., 2004) . As expected, the retention volume of ∆N90-DntR-His 6 during column chromatography was changed compared to that of the full-length protein. Pure protein fractions were pooled and dialysed against a buffer consisting of either (1) 0.4 M NaCl; 20 mM HEPES-NaOH (pH 7.7); 2 mM MgSO 4 ; 17% glycerol; 1 mM DTT or (2) 0.3 M NaCl; 50 mM NaH 2 PO 4 -NaOH (pH 7.5); 2 mM MgSO 4 ; 17% glycerol; 1 mM DTT and concentrated to ~15 mg/ml. Protocol B: 2 l of cells were grown aerobically at 37°C in Luria-Bertani broth supplemented with 100 µl/ml ampicillin and 25 µl/ml kanamycin. When OD 600 reached 0.5 cells were cooled to 20°C and expression induced overnight by the addition of 1 mM IPTG. Cells were harvested by centrifugation and resuspended in 30 ml of a buffer containing 0.3 M NaCl, 25 mM NaH 2 PO 4 -NaOH (pH 8.0), 5 mM imidazole, DNAse I, lysozyme, Complete EDTA-free Protease Inhibitor tablets (Roche) then frozen. For purification, thawed cells were sonicated for 10 minutes on ice, then centrifuged to clarify the cell lysate. The supernatant was loaded onto a 5 ml His-Trap column (GE Healthcare) equilibrated with 5 mM imidazole, 0.3 M NaCl and 25 mM NaH 2 PO 4 -NaOH (pH 8.0). An imidazole gradient of 5 mM to 500 mM in buffer was run on the column. ∆N90-DntR-His 6 eluted at an imdazole concentration of ~250 mM. Pure protein fractions were pooled, dialysed into a buffer comprising 0.3 M NaCl, 2 mM MgSO 4 , 1mM DTT, 5% glycerol and 20 mM NaH 2 PO 4 -NaOH (pH 7.5) and concentrated to 30 mg/ml. ∆ ∆ ∆ ∆N80-DntR: The ∆N80-DntR (M80 -A301) fragment of the DntR gene from Burkholderia sp. DNT was PCR amplified from the vector pLCN60.9 (Ng, 2000) using the primers (forward) TTCCATGGAGACGGCACTGACGACCC and TTCCATGGACCCATTTGCCAGCACG (reverse). As for ∆N90-DntR, the amplicon was ligated into the pQE60 vector and transformed into E.coli M15[pREP4] cells. Expression and purification of ∆N80-DntR-His 6 was carried out using protocol B described above.
Crystallisation apo-∆ ∆ ∆ ∆N80-DntR: 1 µl of the protein stock (0.2 M NaCl; 2 mM MgSO 4 ; 10% glycerol; 20mM
NaH 2 PO 4 -NaOH pH 8; 1mM DTT; 12 mg/ml ∆N90-DntR-His 6 ) was mixed with 1 µl of reservoir solution (0.2 M Na/K Tartrate, 0.1 M Tris pH 8.0; PEG 8000 33%) and equilibrated at 20 o C against 1 ml of the reservoir solution. Long thin needle-shaped crystals appeared after 1 week. For the collection of diffraction data these were flash-cooled at liquid nitrogen temperature in mother liquor supplemented with 20% glycerol. ∆ ∆ ∆ ∆N80-DntR-salicylate: 1 µl protein stock (0.3 M NaCl; 20mM NaH 2 PO 4 -NaOH pH 8; 20 mM Na salicylate; 2 mM MgSO 4 ; 5% glycerol; 1mM DTT; 6-10 mg/ml ∆N80-DntR-His 6 ) was mixed with 1 µl of reservoir solution (0.1M bis-tris pH 6.5, 0.2M MgCl 2 , 25% PEG 3350) and at equilibrated against 1 ml of the reservoir solution at 20 o C. Long thin plate-shaped crystals grew after 1 week. Before X-ray data collection crystals were flash cryo-cooled after cryoprotection in mother liquor supplemented with 20% glycerol and 20mM Na salicylate. apo-∆ ∆ ∆ ∆N90-DntR: 1 µl of the protein stock (0.4 M NaCl; 20 mM HEPES-NaOH pH 7.7; 2 mM MgSO 4 ; 17% glycerol; 1.2 -1.5% N-octyl-β-D-glucopyranoside (OG), 10-12 mg/ml ∆N90-DntR-His 6 ) was mixed with 1 µl of reservoir solution (0.2 M Na/K Tartrate, 0.1 M Tris pH 8.0-8.5; PEG 8000 28-30%) and equilibrated at 18 o C against 1 ml of the reservoir solution. Clumps of long, fragile, very thin, needle-shaped crystals appeared after 4-5 days. The clumps were broken and small crystal fragments scooped into nylon loops along with some crystallisation mother liquor. The crystals were then flash-cryo-cooled at liquid nitrogen temperature without further cryo-protection. ∆ ∆ ∆ ∆N90-DntRsalicylate, crystal form I: Crystallisation was performed as described for apo-∆N90-DntR with the exception that the protein stock comprised 0.3 M NaCl; 0.05 M NaH 2 PO 4 -NaOH pH 7.5; 50 mM Na salicylate; 2 mM MgSO 4 ; 17% glycerol; 1.2-1.5% OG, 12 mg/ml ∆N90-DntR-His 6 . Large hexagonal bi-pyramid-shaped crystals appeared after 7-9 days. For X-ray data collection, these were flash cryocooled after cryoprotection in 0.2 M Na/K Tartrate, 0.1 M Tris pH 8.0; 50 mM Na salicylate; 28% PEG 8000; 10% glycerol. ∆ ∆ ∆ ∆N90-DntR-salicylate, crystal form II: Crystallisation stock comprised a 1:1 mixture of protein stock (protocol B, above) and a buffer containing 400 mM NaCl, 20 mM HEPES pH 7.9, 2 mM MgSO 4 , 20% glycerol, 1 mM DTT, 13 µl 0.5 M Na salicylate in 25 mM HEPES pH 7.9 and 13 µl OG. 4 µl of this was mixed in a 1:1 ratio with a reservoir solution (31% PEG 8000, 0.1 M Tris HCl (pH 8.0) and 0.2 M Na/K tartrate) and equilibrated at room temperature against 1 ml of the reservoir solution. Large, plate-shaped crystals grew in two weeks. For X-ray data collection, crystals were flash cryo-cooled without further cryoprotection.
X-ray data collection and processing
Diffraction data (Table 3) were collected at 100 K on ESRF beamlines ID23-1 (Nurizzo et al., 2006) , ID23-2 (Flot et al., 2010) or ID29 and integrated using either MOSFLM (Leslie, 2006) or XDS (Kabsch, 2010) . In the cases where XDS was used, intensities were converted to mtz format using POINTLESS (Evans, 2005) , and symmetry-related intensities merged using SCALA (Evans, 2005) . For MOSFLM-integrated data SCALA was used both for the scaling and merging of intensities. In all cases structure factors were derived using TRUNCATE (French & Wilson, 1978) .
For ∆N80-DntR-salicylate diffraction data were collected using a helical protocol (Flot et al., 2010) .
For apo-∆N90-DntR the 5 x 7 µm 2 focal spot of ID23-2 was used to isolate two positions in a crystal of approximate dimensions 40 x 10 x 5 µm 3 . A complete diffraction data set was compiled by combining partial datasets obtained at the two positions. For ∆N90-DntR-salicylate, crystal form I two data sets were collected from the same crystal: one for structure solution, the other for refinement.
Structure solution, model building, refinement
apo-∆ ∆ ∆ ∆N80-DntR: RD1 and RD2 of the IBD of subunit A from the crystal structure of acetate-bound full length DntR (PDB code: 1UTB) were used as search models for molecular replacement (MR) calculations using the program PHASER (McCoy et al., 2007) . Refinement of the resulting model was carried out using rounds of manual rebuilding using COOT (Emsley et al., 2010) interspersed with restrained refinement using PHENIX (Adams et al., 1997) . ∆ ∆ ∆ ∆N80-DntR-salicylate: MR calculations using PHASER were carried out with the same search models as for apo-∆N80-DntR. At the end of the protocol, three complete ∆N80-DntR monomers had been placed in the a.u. For the fourth, only RD2 was correctly positioned. RD1 for this monomer was thus placed into the electron density by hand. Refinement of the model consisted of an initial round of rigid body refinement in REFMAC5 (Murshudov et al., 1997) rounds of manual rebuilding using COOT interspersed with restrained refinement using REFMAC5 during which NCS restraints were applied. ∆ ∆ ∆ ∆N90-DntR-salicylate, crystal form I:: This crystal structure was solved using the S-SAD technique (Dauter et al., 1999) . SHELXD (Schneider & Sheldrick, 2002) was used to determine the sulphur atom substructure, SHELXE (Sheldrick, 2008) to derive phase probability distributions to d min = 2.3 Å, ARP/wARP (Perrakis et al.,1999) for automatic model building. The model was completed manually using COOT then used as a search model in MR calculations using PHASER against the high-resolution dataset. Refinement then consisted of rounds of manual rebuilding using COOT interspersed with restrained refinement using REFMAC5. ∆ ∆ ∆ ∆N90-DntR-salicylate, crystal form II:: RD1 and RD2 of a partially refined model of ∆N90-DntRsalicylate, crystal form I provided the search model for MR calculations with PHASER. Subsequent structure refinement was carried out as for crystal form I.
A summary of refinement statistics and the composition and geometry of all final models is given in Table 3 .
Intrinsic fluorescence quenching upon inducer binding
Inducer binding to ∆N90-DntR-His 6 was monitored as quenching of the protein intrinsic fluorescence (Tetin & Hazlett, 2000) . Fluorescence measurements and data treatment were carried 20 out mainly as described before (Smirnova et al., 2004) . Protein fluorescence spectra (280-400 nm) were recorded at 22 0 C with excitation at 274 nm using Fluorolog (Horiba) . Emission values at 326 nm were used in the data processing. The incubation medium consisted of 50 mM NaH 2 PO 4 -NaOH (pH 7.7); 0.1 M Na 2 SO 4 ; 17% glycerol and ∆N90-DntR-His 6 concentrations were 1.5 -2 µM. High concentrations of salicylate could not be used owing to undesirable internal filter effect. The K d was estimated with the aid of the program SigmaPlot10 (SPSS Inc.) by a least square fit to the equation: 
Isothermal titration calorimetry
ITC was carried out at 22°C (∆N90-DntR, wt-DntR) or 15°C (∆N80-DntR) using a VP-ITC Microcal calorimeter (Microcal, Northampton, MA, USA). Prior to all measurements, all proteins were freshly purified and dialysed against a buffer comprising 400 mM NaCl, 20 mM HEPES pH 7.9, 2 mM MgSO 4 , 5% glycerol. For wt-DntR, 1mM DTT was also added. A 1 M Na salicylate stock solution was prepared in the same ITC buffer and was diluted sequentially to obtained 1mM and 1.5mM stock solutions. Titrations consisted of 5-7 µL aliquot injections made at time intervals of 5 min to ensure that the titration peak returned to the baseline. Data were analyzed and corrected for the heat of dilution of injectant into buffer using program Origin (v5.0) provided by the manufacturer.
Construction, growth and flow cytometric analysis of whole cell systems
The mutations R97C, F90A and S95A were introduced to the wt-DntR gene carried on the plasmid pQEwtdntRHis6:P DNT :gfp using a site-directed mutagenesis kit (Stratagene, La Jolla, CA, USA) according to the manufacturer's instructions. Introduction of the correct mutations was confirmed by sequencing. Prior to analysis, E.coli DH5α cells were transformed with the relevant plasmid. Cells were cultured in M9 medium (1 x Difco M9 minimal salts, 1 mM MgSO 4 , 0.1 mM CaCl 2 , 0.2% glucose, 0.7mg/ml of each amino acid) supplied with 100 µg/ml ampicillin for maintenance of the plasmid at 30˚C with shaking. Freshly transformed cells were grown overnight, then 1 ml cultures were inoculated to an OD 600 of 0.05. After 2h, salicylate was added at a 1:1000 dilution from DMSO stock-solutions with final concentrations in range of 1-1000 µM. Cultures were also grown adding 500 µM 4-NB with or without 500 µM salicylate. 4h and 22h after induction, The protein is shown in cartoon representation. RD1 is shown in yellow, RD2 in magenta. Amino acids at the RD1/RD2 hinge region are shown in cyan, those at the extreme N-terminus in black.
Secondary structure elements are labelled as defined for full-length LTTRs (Monferrer et al., 2010) .
The monomer shown is subunit A from apo-∆N90-DntR. The dimer is the A/E dimer from the same crystal form. Figures 1, 2, 3 , 4, and 6 were created using PyMol (The PyMoL Molecular Graphics System, Schrödinger, LLC; http://www.pymol.org/). 
